<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01012050</url>
  </required_header>
  <id_info>
    <org_study_id>VNI1972NEB</org_study_id>
    <nct_id>NCT01012050</nct_id>
  </id_info>
  <brief_title>Radioaerosol Pulmonary Deposition During Asthma Exacerbation Through Noninvasive Ventilation</brief_title>
  <acronym>NV</acronym>
  <official_title>Analysing the Effects of Coupling Nebulization to Noninvasive Ventilation Through Pulmonary Scintigraphy on the Radioaerosol Deposition During Asthma Exacerbation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the physiologic and clinical effects provided by coupling nebulization with
      noninvasive ventilation in asthma exacerbation, there are few and controversial studies
      reported in the literature.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Reduced work of breathing, increased oxygenation and increased in expiratory peak flow (EPF)
      and forced expiratory volume in the first second (FEV1) are benefits of noninvasive
      ventilation (NV) in the treatment of asthma. Despite these clinical improvements attributed
      to NV during asthma exacerbations and the well-established effects of nebulization, there are
      few studies in the literature coupling both therapeutic resources.

      In addition to this, no studies on scintigraphic analysis of radioaerosol deposition coupled
      with NV in asthmatics have published. A previous study was published by our group, but
      involved healthy subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary characteristics</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radioaerosol pulmonary index, radioaerosol penetration index and pulmonary clearance.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>NV Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Performed nebulization coupled with noninvasive ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NEB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Performed nebulization alone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NV</intervention_name>
    <description>Noninvasive ventilation coupled with nebulization(Nebulization containing salbutamol (2.5mg) and ipratropium bromide (0.25mg)plus oxygen flow in 7Lpm)</description>
    <arm_group_label>NV Group</arm_group_label>
    <other_name>Interventional Group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NEB group</intervention_name>
    <description>Nebulization containing salbutamol (2.5mg) and ipratropium bromide (0.25mg)plus oxygen flow in 7Lpm</description>
    <arm_group_label>NEB group</arm_group_label>
    <other_name>Control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of moderate to severe asthma (FEV1 &lt; 60 % of predicted values)

          -  Breathing rate &gt; 25 bpm

          -  History of asthma for at least 1 year

          -  Duration of current asthma attack of &lt; 7 days

          -  Reversibility of FEV1 of at least ≤ 10% after the administration of bronchodilator
             drugs

        Exclusion Criteria:

          -  Current smoker

          -  Presence of cardiopulmonary disease (COPD, pneumonia, heart failure, myocardial
             infarction, pneumothorax)

          -  Hyperthermia

          -  Indication of intubation and invasive mechanical ventilation;

          -  Hemodynamic instability (heart rate &gt; 150 bpm and systolic blood pressure &lt; 90 mmHg)

          -  Cardiac arrhythmia

          -  Changes in consciousness

          -  Pregnancy

          -  Contraindications to use NV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valdecir C Galindo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal de Pernambuco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Valdecir Castor Galindo Filho</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.nlm.nih.gov/medlineplus/asthma.html</url>
  </link>
  <link>
    <url>http://www.asthma.org.uk/</url>
  </link>
  <reference>
    <citation>Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest. 2003 Apr;123(4):1018-25.</citation>
    <PMID>12684289</PMID>
  </reference>
  <reference>
    <citation>França EE, Dornelas de Andrade AF, Cabral G, Almeida Filho P, Silva KC, Galindo Filho VC, Marinho PE, Lemos A, Parreira VF. Nebulization associated with bi-level noninvasive ventilation: analysis of pulmonary radioaerosol deposition. Respir Med. 2006 Apr;100(4):721-8. Epub 2005 Aug 31.</citation>
    <PMID>16139491</PMID>
  </reference>
  <reference>
    <citation>Soma T, Hino M, Kida K, Kudoh S. A prospective and randomized study for improvement of acute asthma by non-invasive positive pressure ventilation (NPPV). Intern Med. 2008;47(6):493-501. Epub 2008 Mar 17.</citation>
    <PMID>18344635</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2009</study_first_submitted>
  <study_first_submitted_qc>November 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2009</study_first_posted>
  <last_update_submitted>November 10, 2009</last_update_submitted>
  <last_update_submitted_qc>November 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>Valdecir Castor Galindo Filho</name_title>
    <organization>Universidade Federal de Pernambuco</organization>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>status asthmatics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

